This form of radiation therapy uses alpha particles, a type of radiation with high energy and short path length in tissue, to precisely destroy cancer cells while minimizing damage to surrounding healthy tissues. For instance, specialized molecules can be designed to carry the alpha-emitting substances directly to tumor cells, effectively delivering a highly localized dose of radiation.
The precision of this approach offers the potential for increased efficacy in treating certain cancers, particularly those that are difficult to reach or resistant to conventional therapies. By concentrating the radiation dose on the tumor, the impact on healthy tissues can be significantly reduced, leading to fewer side effects for patients. The development of this technology has been driven by the need for more effective and less toxic cancer treatments, and represents a significant advancement in the field of radiation oncology.
